Literature DB >> 16267726

Acquired metallo-beta-lactamases: an increasing clinical threat.

Gian Maria Rossolini.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16267726     DOI: 10.1086/497839

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  14 in total

1.  Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.

Authors:  Rodrigo E Mendes; Jan M Bell; John D Turnidge; Qiwen Yang; Yunsong Yu; Ziyong Sun; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

2.  First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.

Authors:  Wojciech Duljasz; Marek Gniadkowski; Silvia Sitter; Alexandra Wojna; Crista Jebelean
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

3.  Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

Authors:  Maria Souli; Panagiota Danai Rekatsina; Zoi Chryssouli; Irene Galani; Helen Giamarellou; Kyriaki Kanellakopoulou
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

4.  Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing.

Authors:  Christian G Giske; Balázs Libisch; Céline Colinon; Effie Scoulica; Laura Pagani; Miklós Füzi; Göran Kronvall; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

5.  Molecular epidemiology of VIM-4 metallo-beta-lactamase-producing Pseudomonas sp. isolates in Hungary.

Authors:  Balázs Libisch; Mónika Muzslay; Mária Gacs; János Minárovits; Márta Knausz; Joseph Watine; Gábor Ternák; Eva Kenéz; Ildikó Kustos; László Rókusz; Klára Széles; Boglárka Balogh; Miklós Füzi
Journal:  Antimicrob Agents Chemother       Date:  2006-09-25       Impact factor: 5.191

6.  Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates.

Authors:  Johann D D Pitout; Barbara L Chow; Daniel B Gregson; Kevin B Laupland; Sameer Elsayed; Deirdre L Church
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

7.  Tetracyclic indolines as a novel class of β-lactam-selective resistance-modifying agent for MRSA.

Authors:  Yugen Zhu; Lakota Cleaver; Wei Wang; Jessica D Podoll; Shane Walls; Austin Jolly; Xiang Wang
Journal:  Eur J Med Chem       Date:  2016-09-10       Impact factor: 6.514

8.  Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Mariana Castanheira; Hélio S Sader; Lalitagauri M Deshpande; Thomas R Fritsche; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

9.  Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio.

Authors:  Federico Perez; Andrea M Hujer; Steven H Marshall; Amy J Ray; Philip N Rather; Nuntra Suwantarat; Donald Dumford; Patrick O'Shea; T Nicholas J Domitrovic; Robert A Salata; Kalyan D Chavda; Liang Chen; Barry N Kreiswirth; Alejandro J Vila; Susanne Haussler; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

10.  Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies.

Authors:  Agnese Lupo; Sébastien Coyne; Thomas Ulrich Berendonk
Journal:  Front Microbiol       Date:  2012-01-26       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.